Clinical Trial Update: Long-term, Open-label Study of SAR447537 (INBRX-101) in Adults With Alpha-1 Antitrypsin Deficiency Emphysema [Phase 2]

View source ↗

Summary

Open-label Phase 2 long-term study of SAR447537 (INBRX-101) in adults with Alpha-1 antitrypsin deficiency–emphysema; the trial is currently active but not recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alpha-1 Antitrypsin Deficiency
• Emphysema

Drugs mentioned

• SAR447537 (INBRX-101) (SAR447537)

Snippet

Sponsor: Sanofi | Conditions: Alpha 1-Antitrypsin Deficiency, Emphysema | Phase 2 | Status: ACTIVE_NOT_RECRUITING